(Q42269612)

English

Psychometric evaluation of the hepatitis C virus patient-reported outcomes (HCV-PRO) instrument: validity, responsiveness, and identification of the minimally important difference in a phase 2 clinical trial

scientific article published on 14 September 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Psychometric evaluation of the hepatitis C virus patient-reported outcomes (HCV-PRO) instrument: validity, responsiveness, and identification of the minimally important difference in a phase 2 clinical trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

phase II clinical trial

0 references

Hepatitis C virus

1 reference

based on heuristic

inferred from title

author name string

Roger T Anderson

1

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Robert W Baran

2

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Pennifer Erickson

3

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Dennis A Revicki

4

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Birgitta Dietz

5

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Katherine Gooch

6

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

publication date

14 September 2013

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Quality of Life Research

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

23

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

877-886

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

https://scigraph.springernature.com/pub.10.1007/s11136-013-0519-1

0 references

Aging of hepatitis C virus (HCV)-infected persons in the United States: a multiple cohort model of HCV prevalence and disease progression

1 reference

https://api.crossref.org/works/10.1007%2FS11136-013-0519-1

21 January 2018

Health-related quality of life in chronic hepatitis C: impact of disease and treatment response. The Interventional Therapy Group.

1 reference

https://api.crossref.org/works/10.1007%2FS11136-013-0519-1

21 January 2018

The effects of HCV infection and management on health-related quality of life

1 reference

https://api.crossref.org/works/10.1007%2FS11136-013-0519-1

21 January 2018

Health utilities and psychometric quality of life in patients with early- and late-stage hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1007%2FS11136-013-0519-1

21 January 2018

Humanistic and economic impacts of hepatitis C infection in the United States

1 reference

https://api.crossref.org/works/10.1007%2FS11136-013-0519-1

21 January 2018

Diagnosis, management, and treatment of hepatitis C: an update

1 reference

https://api.crossref.org/works/10.1007%2FS11136-013-0519-1

21 January 2018

Estimation of utilities for chronic hepatitis C from SF-36 scores

1 reference

https://api.crossref.org/works/10.1007%2FS11136-013-0519-1

21 January 2018

The impact of peginterferon alfa-2a plus ribavirin combination therapy on health-related quality of life in chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1007%2FS11136-013-0519-1

21 January 2018

Relationship of health-related quality of life to treatment adherence and sustained response in chronic hepatitis C patients

1 reference

https://api.crossref.org/works/10.1007%2FS11136-013-0519-1

21 January 2018

Recommended methods for determining responsiveness and minimally important differences for patient-reported outcomes

1 reference

https://api.crossref.org/works/10.1007%2FS11136-013-0519-1

21 January 2018

EuroQol--a new facility for the measurement of health-related quality of life

1 reference

https://api.crossref.org/works/10.1007%2FS11136-013-0519-1

21 January 2018

It's good to feel better but it's better to feel good and even better to feel good as soon as possible for as long as possible. Response criteria and the importance of change at OMERACT 10.

1 reference

https://api.crossref.org/works/10.1007%2FS11136-013-0519-1

21 January 2018

Impact of hepatitis C on health related quality of life: a systematic review and quantitative assessment

1 reference

https://api.crossref.org/works/10.1007%2FS11136-013-0519-1

21 January 2018

Evaluation of the meaningfulness of health-related quality of life improvements as assessed by the SF-36 and the EQ-5D VAS in patients with active Crohn's disease

1 reference

https://api.crossref.org/works/10.1007%2FS11136-013-0519-1

21 January 2018

Development and evaluation of the Liver Disease Quality of Life instrument in persons with advanced, chronic liver disease--the LDQOL 1.0.

1 reference

https://pubmed.ncbi.nlm.nih.gov/24036634

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Recommendations for the identification of chronic hepatitis C virus infection among persons born during 1945-1965.

1 reference

https://pubmed.ncbi.nlm.nih.gov/24036634

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Development and initial psychometric evaluation of the hepatitis C virus-patient-reported outcomes (HCV-PRO) instrument

1 reference

https://pubmed.ncbi.nlm.nih.gov/24036634

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Gamma-glutamyltransferase and rapid virological response as predictors of successful treatment with experimental or standard peginterferon-alpha-2b in chronic hepatitis C non-responders

1 reference

https://pubmed.ncbi.nlm.nih.gov/24036634

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A questionnaire to assess the generic and disease-specific health outcomes of patients with chronic hepatitis C

1 reference

https://pubmed.ncbi.nlm.nih.gov/24036634

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S11136-013-0519-1

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42269612&oldid=1940747607"